BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 2859725)

  • 1. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
    Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct effects of thyrotropin-releasing hormone, cyproheptadine, and dopamine on adrenocorticotropin secretion from human corticotroph adenoma cells in vitro.
    Ishibashi M; Yamaji T
    J Clin Invest; 1981 Oct; 68(4):1018-27. PubMed ID: 6270192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective bilateral and simultaneous catheterization of the inferior petrosal sinus: CRF stimulates prolactin secretion from ACTH-producing microadenomas in Cushing's disease.
    Schulte HM; Allolio B; Günther RW; Benker G; Winkelmann W; Ohnhaus EE; Reinwein D
    Clin Endocrinol (Oxf); 1988 Mar; 28(3):289-95. PubMed ID: 2844450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACTH and beta-endorphin secretion by three corticotrophic adenomas in culture. Effects of culture time, dexamethasone, vasopressin and synthetic corticotrophin releasing factor.
    Oosterom R; Verleun T; Uitterlinden P; Hackeng WH; Burbach JP; Wiegant VM; Lamberts SW
    Acta Endocrinol (Copenh); 1984 May; 106(1):21-9. PubMed ID: 6328819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of corticotropin-releasing factor and other materials on adrenocorticotropin secretion from pituitary glands of patients with Cushing's disease in vitro.
    Suda T; Tomori N; Tozawa F; Demura H; Shizume K
    J Clin Endocrinol Metab; 1984 Nov; 59(5):840-5. PubMed ID: 6148354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma.
    Comtois R; Beauregard H; Hardy J; Robert F; Somma M
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):601-7. PubMed ID: 8392915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACTH response to desmopressin in a patient with acromegaly; expression of corticotropin-releasing factor, urocortins and vasopressin V1b receptor in GH-producing pituitary adenoma.
    Arihara Z; Sakurai K; Osaki Y; Fukazawa H; Yamada S; Inoshita N; Murakami O; Ohba K; Takahashi K
    Endocr J; 2011; 58(12):1029-36. PubMed ID: 21908929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture.
    Matsuno A; Sasaki T; Mochizuki T; Fujimaki T; Sanno N; Osamura Y; Teramoto A; Kirino T
    Acta Neurochir (Wien); 1996; 138(8):1002-7. PubMed ID: 8890999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ovine corticotrophin releasing factor, bromocriptine, and dopamine on release of ACTH and beta-endorphin in a patient with Cushing's disease.
    Nakashima H; Hirata Y; Uchihashi M; Tomita M; Fujita T
    Acta Endocrinol (Copenh); 1985 May; 109(1):7-12. PubMed ID: 2988259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of GnRH-associated peptide on prolactin secretion from human lactotrope adenoma cells in culture.
    Ishibashi M; Yamaji T; Takaku F; Teramoto A; Fukushima T; Toyama M; Kamoi K
    Acta Endocrinol (Copenh); 1987 Sep; 116(1):81-4. PubMed ID: 3310494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
    Lamberts SW; Verleun T; Oosterom R; de Jong F; Hackeng WH
    J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of ovine corticotrophin releasing factor (oCRF), bromocriptine and TRH on the secretion of ACTH and alpha-MSH in Nelson's syndrome and Cushing's disease.
    Abraham RR; Campbell EA; Gillham B; Thody AJ; Altaher AR; Prysor-Jones A; Wynn V; Jones MT; Jenkins J
    Clin Endocrinol (Oxf); 1986 Jul; 25(1):75-85. PubMed ID: 3024873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of prolactin secretion in patients with Cushing's disease. A comparative study on the effects of dexamethasone, lysine vasopressin and ACTH on prolactin secretion by the rat pituitary gland in vitro.
    Lamberts SW; de Quijada M; Visser TJ
    Neuroendocrinology; 1981 Mar; 32(3):150-4. PubMed ID: 6261178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin secretion from human prolactinomas perifused in vitro: effect of TRH, prostaglandin E1, theophylline, dopamine and dopamine receptor blockers.
    Chihara K; Iwasaki J; Minamitani N; Kaji H; Kodama H; Fujita T; Shirataki K; Tamaki N; Matsumoto S
    Acta Endocrinol (Copenh); 1984 Jan; 105(1):6-13. PubMed ID: 6421041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive intestinal polypeptide enhances ACTH levels in some patients with adrenocorticotropin-secreting pituitary adenomas.
    Ambrosi B; Bochicchio D; Sartorio A; Morabito F; Faglia G
    Acta Endocrinol (Copenh); 1987 Oct; 116(2):216-20. PubMed ID: 2821720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenomas that caused Cushing's disease or Nelson's syndrome are not responsive to ovine corticotropin-releasing factor in vitro.
    Shibasaki T; Nakahara M; Shizume K; Kiyosawa Y; Suda T; Demura H; Kuwayama A; Kageyama N; Benoit R; Ling N
    J Clin Endocrinol Metab; 1983 Feb; 56(2):414-6. PubMed ID: 6130101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.